S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 21 of 21

Issue Date	Title / Author(s) / Citation	File
2006-08	First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Yoon, Sung-Soo; Heo, Dae Seog; Bang, Yung-Jue; Park, Seonyang; Kim, Byoung Kook; Kim, Noe Kyeong Leuk Lymphoma. 2006 Jul;47(7):1274-82.	link
2007-06	Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy Jung, Yeonjoo; Park, Jinah; Kim, Tai Young; Park, Jung-Hyun; Jong, Hyun-Soon; Im, Seock-Ah; Robertson, Keith D; Bang, Yung-Jue; Kim, Tae-You J Mol Med. 2007 Oct;85(10):1137-48. Epub 2007 Jun 15.	link
2008-03	Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells Lee, Keun-Wook; Kim, Sang Gyun; Kim, Hwang-Phill; Kwon, Euna; You, Jiran; Choi, Hyung-Jun; Park, Jung-Hyun; Kang, Byeong-Cheol; Im, Seock-Ah; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Res. 2008 Mar 15;68(6):1916-26.	link
2008-03	Weight changes after adjuvant treatment in Korean women with early breast cancer Han, Hye-Suk; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Sung-Won; Kim, In-Ah; Oh, Do-Youn; Im, Seock-Ah; Bang, Soo-Mee; Lee, Jong Seok Breast Cancer Res Treat. 2009 ;114(1):147-53.	link
2008-10	Ongoing debates in the assessment of the HER2 status in breast cancer: A comparative analysis by immunohistochemistry and FISH using original FDA and ASCO/CAP guidelines Ko, Hyoungsuk; Seol, Hyesil; Kim, Wook Youn; Im, Seock-Ah; Han, Wonshik; Noh, Dong-Young; Jeon, Yoon Kyung; Park, In Ae Bas Appl Pathol 2008; 1: 182-188	DOI
2008-12	Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer Kim, Kyubo; Chie, Eui Kyu; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W Jpn J Clin Oncol. 2009 Feb;39(2):111-5. Epub 2008 Dec 5.	link
2009-01	Neoadjuvant Chemotherapy Followed by Limited Surgery in a Mouse Model of Head and Neck Cancer Lee, Jae Jin; Hah, Jeong-Hun; Im, Seock-Ah; Kim, Si-Young; Kim, Kwang Hyun; Heo, Dae Soeg; Sung, Myung-Whun ANTICANCER RESEARCH; Vol.29 1; 255-259
2009-01	Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study Lee, Jeeyun; Jung, Kyung Hae; Park, Young Suk; Ahn, Joong Bae; Shin, Sang Jun; Im, Seock-Ah; Oh, Do Youn; Shin, Dong Bok; Kim, Tae Won; Lee, Namsu; Byun, Jae Ho; Hong, Yong Sang; Park, Joon Oh; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki Cancer Chemother Pharmacol. 2009 Sep;64(4):657-63. Epub 2009 Jan 24.	link
2009-02	Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer Jung, So-Youn; Han, Wonshik; Lee, Jong Won; Ko, Eunyoung; Kim, Eunkyu; Yu, Jong-Han; Moon, Hyeong-Gon; Park, In Ae; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Hwang, Ki-Tae; Kim, Sung-Won; Noh, Dong-Young Ann Surg Oncol. 2009;16:1112-21	DOI
2010-12	Combination Chemotherapy with S-1 and Platinum in Advanced Hepatocellular Carcinoma Kim, Su-Jung; Han, Sae-Won; Oh, Do-Youn; Yi, Nam-Joon; Im, Seock-Ah; Kang, Gyeong Hoon; Bang, Yung-Jue; Kim, Tae-You; Jang, Ja-Joon; Suh, Kyung Suk; Yoon, Jung-Hwan; Kim, Yoon Jun ANTICANCER RESEARCH; Vol.30 12; 5245-5250
2012-07	Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer Kim, Jisun; Han, Wonshik; Moon, Hyeong-Gon; Ahn, Soo Kyung; Shin, Hee-Chul; You, Jee-Man; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Koo, Hye Ryoung; Chang, Jung Min; Cho, Nariya; Moon, Woo Kyung; Noh, Dong-Young Breast Cancer Research, 14(4):R102	view file DOI
2013-12	The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer Lee, Joo Ho; Chie, Eui Kyu; Kim, Kyubo; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kang, Gyeong Hoon; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Ha, Sung W BMC Cancer Vol.13, pp. 1-9	view file link
2015-03	Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells Min, Ahrum; Im, Seock-Ah; Kim, Debora Keunyoung; Song, Sang-Hyun; Kim, Hee-Jun; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; O’Connor, Mark J O'Connor; Bang, Yung-Jue Breast Cancer Research, 17(1):33	view file DOI
2020-03	Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies Ettl, Johannes; Im, Seock-Ah; Ro, Jungsil; Masuda, Norikazu; Colleoni, Marco; Schnell, Patrick; Bananis, Eustratios; Lu, Dongrui R; Cristofanilli, Massimo; Rugo, Hope S; Finn, Richard S Breast Cancer Research. 2020 Mar 12;22(1):27	view file link
2021-01	A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer Schmid, Peter; Sablin, Marie-Paule; Bergh, Jonas; Im, Seock-Ah; Lu, Yen-Shen; Martínez, Noelia; Neven, Patrick; Lee, Keun Seok; Morales, Serafín; Pérez-Fidalgo, J. A; Adamson, Douglas; Gonçalves, Anthony; Prat, Aleix; Jerusalem, Guy; Schlieker, Laura; Espadero, Rosa-Maria; Bogenrieder, Thomas; Huang, Dennis C; Crown, John; Cortés, Javier Breast Cancer Research. 2021 Jan 15;23(1):8	view file DOI
2021-04	Correction to: Development of a Novel Orthotopic Gastric Cancer Mouse Model Kang, Wonyoung; Maher, Leigh; Michaud, Michael; Bae, Seong-Woo; Kim, Seongyeong; Lee, Hye S; Im, Seock-Ah; Yang, Han-Kwang; Lee, Charles Biological Procedures Online. 2021 Apr 07;23(1):9	view file link
2022-02	The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology Hirko, Kelly A.; Rocque, Gabrielle; Reasor, Erica; Taye, Ammanuel; Daly, Alex; Cutress, Ramsey I.; Copson, Ellen R.; Lee, Dae-Won; Lee, Kyung-Hun; Im, Seock-Ah; Park, Yeon H. BMC Medicine. 2022 Feb 11;20(1):72	view file link
2022-03	HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis Tan, Ryan S. Y. C.; Ong, Whee S.; Lee, Kyung-Hun; Lim, Abner H.; Park, Seri; Park, Yeon H.; Lin, Ching-Hung; Lu, Yen-Shen; Ono, Makiko; Ueno, Takayuki; Naito, Yoichi; Onishi, Tatsuya; Lim, Geok-Hoon; Tan, Su-Ming; Lee, Han-Byoel; Ryu, Han S.; Han, Wonshik; Tan, Veronique K. M.; Wong, Fuh-Yong; Im, Seock-Ah; Tan, Puay H.; Chan, Jason Y.; Yap, Yoon-Sim BMC Medicine. 2022 Mar 17;20(1):105	view file link
2023-07	Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer Park, Yeon Hee; Im, Seock-Ah; Park, Kyunghee; Wen, Ji; Lee, Kyung-Hun; Choi, Yoon-La; Lee, Won-Chul; Min, Ahrum; Bonato, Vinicius; Park, Seri; Ram, Sripad; Lee, Dae-Won; Kim, Ji-Yeon; Lee, Su Kyeong; Lee, Won-Woo; Lee, Jisook; Kim, Miso; Kim, Hyun Seon; Weinrich, Scott L.; Ryu, Han Suk; Kim, Tae Yong; Dann, Stephen; Kim, Yu-Jin; Fernandez, Diane R.; Koh, Jiwon; Wang, Shuoguo; Park, Song Yi; Deng, Shibing; Powell, Eric; Ravi, Rupesh K.; Bienkowska, Jadwiga; Rejto, Paul A.; Park, Woong-Yang; Kan, Zhengyan Genome Medicine, Vol.15(1):55	view file DOI
2023-11	The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancer Choi, Ji Eun; Lee, Jae Seok; Jin, Min-Sun; Nikas, Ilias P.; Kim, Kwangsoo; Yang, Sunah; Park, Soo Young; Koh, Jiwon; Yang, Sohyeon; Im, Seock-Ah; Ryu, Han Suk Breast Cancer Research, Vol.25(1):134	view file DOI
2023-12	HER2 amplification level by in situ hybridization predicts survival outcome in advanced HER2-positive breast cancer treated with pertuzumab, trastuzumab, and docetaxel regardless of HER2 IHC results Seo, Jeongmin; Koh, Jiwon; Lee, Dae-Won; Kim, Jinyong; Ryu, Han Suk; Lee, Kyung-Hun; Kim, Tae-Yong; Im, Seock-Ah Breast Cancer Research, Vol.25(1):154	view file DOI